Xylem Other Income (Expense) decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $4.00M to $0.00.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.00M | $2.00M | -$1.00M | -$1.00M | $2.00M | $1.00M | $5.00M | $4.00M | $7.00M | $8.00M | $14.00M | $6.00M | $4.00M | $1.00M | $5.00M | $4.00M | $3.00M | $6.00M | $5.00M | $0.00 |
| QoQ Change | — | +166.7% | -150.0% | +0.0% | +300.0% | -50.0% | +400.0% | -20.0% | +75.0% | +14.3% | +75.0% | -57.1% | -33.3% | -75.0% | +400.0% | -20.0% | -25.0% | +100.0% | -16.7% | -100.0% |
| YoY Change | — | — | — | — | +166.7% | -50.0% | +600.0% | +500.0% | +250.0% | +700.0% | +180.0% | +50.0% | -42.9% | -87.5% | -64.3% | -33.3% | -25.0% | +500.0% | +0.0% | -100.0% |